"Masculinizing" effect on respiratory morbidity in girls from unlike-sex preterm twins: a possible transchorionic

Eric S Shinwell1, Brian Reichman, Liat Lerner-Geva

  • 1Department of Neonatology, Kaplan Medical Center, PO Box 1, Rehovot 76100, Israel. eric_s@clalit.org.il

Pediatrics
|September 4, 2007
PubMed

Insights

Male premature infants face higher risks for mortality and respiratory issues. However, in unlike-sex twin pairs, this male disadvantage appears transferable to female infants, suggesting intrauterine influences on fetal development.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Fetal Development

Background:

  • Male preterm infants exhibit higher rates of respiratory and neurologic morbidity and mortality compared to females.
  • Female infants in unlike-sex twin pairs show birth weights closer to their male co-twins than to females in like-sex pairs.

Purpose of the Study:

  • To investigate if male disadvantage in preterm infants impacts respiratory distress syndrome (RDS) incidence in female infants from unlike-sex twin pairs.
  • To explore potential intrauterine factors affecting fetal lung development and their sex-specific outcomes.

Main Methods:

  • Population-based study using the Israel Neonatal Network data.
  • Included 8858 very low birth weight infants (500-1500g) from 24 to 34 weeks' gestation.
  • Compared morbidity and mortality in male/female singletons, like-sex twins, and unlike-sex twins using multivariable analyses.

Main Results:

  • Male singletons and like-sex twins had increased risks for mortality, RDS, pneumothorax, bronchopulmonary dysplasia, and brain hemorrhages.
  • No significant difference in respiratory morbidity was observed between males and females in unlike-sex twin pairs.
  • The male disadvantage persisted for mortality and periventricular-intraventricular hemorrhage in unlike-sex pairs.

Conclusions:

  • The observed differences in morbidity and mortality highlight a male disadvantage in preterm infants, not a female advantage.
  • This male disadvantage may be transferred to female co-twins in unlike-sex pairs, potentially via intrauterine paracrine mechanisms.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...
The Y Chromosome Determines Maleness02:19

The Y Chromosome Determines Maleness

The Y chromosome is a sex chromosome found in several vertebrates and mammals, including humans. In addition to 22 pairs of autosomes, the human males have one X chromosome and one Y chromosome. In these organisms, the presence or absence of the Y chromosome determines the development of male traits.
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...